Navigation Links
Chipscreen and HUYA Bioscience to Present Clinical Data on Novel HDAC Inhibitor at the 2009 ASCO Annual Meeting
Date:5/28/2009

SHENZHEN, China and SAN DIEGO, May 28 /PRNewswire/ -- Shenzhen Chipscreen Biosciences, Ltd., and HUYA Bioscience International, LLC, today announced that final data from a Phase 1 trial conducted by Chipscreen of the investigational compound chidamide (CS055/HBI-8000) will be presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held from May 29 to June 2, 2009, in Orlando, Florida. Chidamide/HBI-8000 is a novel benzamide class histone deacetylase (HDAC) inhibitor in development by Chipscreen and HUYA for oncology indications. The data to be presented will include safety, pharmacokinetics, and biomarker and anti-tumor activity (abstract #3529).

                  Title:  "Phase 1 study of chidamide (CS055/HBI-8000), a
                          novel histone deacetylase inhibitor, in patients
                          with advanced solid tumors and lymphomas"

    Poster Presentation:  Friday, May 29, 2 pm - 6 pm EDT, Level 3, W315A,
                          Board 13

      Poster Discussion:  Friday, May 29, 5 pm - 6 pm EDT, Level 4, Valencia
                          Room, W415D

Shenzhen Chipscreen Biosciences is a leading China-based biotechnology company that specializes in discovering and developing proprietary small molecule therapeutics for unmet medical needs. The company is utilizing its proprietary chemical genomics-based discovery platform to develop a portfolio of clinical and preclinical stage programs in a number of therapeutic areas. The core competence of the company is the science-driven approach in discovery, strong pipeline building capability, experience with IP, and regulatory expertise. Additional information about the company is available at www.chipscreen.com.

HUYA Bioscience International is a leader in enabling and accelerating the global co-development of no
'/>"/>

SOURCE HUYA Bioscience International, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Chipscreen Biosciences and HUYA Bioscience Intl Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer
2. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
3. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
4. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
5. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
6. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
7. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
8. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
9. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
10. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
11. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014 Redspin, Inc., ... penetration testing services, today released an IT security advisory ... "Today,s healthcare CEOs are presiding over the most ... Daniel W. Berger , Redspin,s President and CEO. ... and their Boards of Directors understand why they need ...
(Date:9/2/2014)... ATLANTA , Sept. 2, 2014  For over a ... show no link between vaccines and autism. But at least ... In a statement , William Thompson ... significant information" linking the MMR vaccine to an increased risk ... of the same data suggests that African American males ...
(Date:9/2/2014)... Calif. , Sept. 2, 2014 /PRNewswire-iReach/ -- ... just recognized as one of the fastest growing ... past few years, the company has undergone significant ... research, late phase global clinical development, anti-viral and ... 2 years, WCCT Global has successfully participated in ...
Breaking Medicine Technology:CDC vaccine scientist admits wrongdoing. 2CDC vaccine scientist admits wrongdoing. 3Contract Research Organization WCCT Global Celebrates Being Named as One of the Fastest Growing Companies in America 2
... SweetSpot Diabetes Care, Inc. has registered their ... Device Data System (MDDS) with the FDA the Company announced ... Sessions meeting in San Diego, CA. With the ... of data from patient diabetes devices to research tools and ...
... Golden Meditech Holdings Limited ("Golden Meditech" or the "Group," ... that the Group has accumulated 754,791 ordinary shares in its ... the open market between December 2010 and March 2011. As ... the issued share capital of CCBC. CCBC is ...
Cached Medicine Technology:Golden Meditech to Increase Stake in NYSE-listed Affiliate -- China Cord Blood Corporation to 39.5% 2
(Date:9/2/2014)... At the world-famous Magic Castle in Hollywood, California, famed ... being the first and only female staff Medium. Throughout the ... female magician to hold such a position. , “I’m deeply ... says Misty Lee. “Even since I was a child, magic ... can fascinate guests in much the same way.” , At ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 QueenBeeTickets.com , ... events, is now stocking James Taylor concert tickets for the ... select U.S. cities from November 1 to the 19th. , ... and again on the 4th of the month. General onsales ... fans are all set to obtain seats for one of ...
(Date:9/2/2014)... the U.S. has led to public debate about whether ... In January, President Obama also publically stated he is ... Despite the recent shift in views toward marijuana, the ... not well understood. , Now a new ... US High School Seniors: A Comparison of Alcohol and ...
(Date:9/2/2014)... Smile Squared, a well-known Buy One, Give One ... US-made toothbrush. For every toothbrush purchased, Smile Squared gives ... was created by my wife and me after volunteering ... President of Smile Squared. “There, we saw children who ... of the same children didn't own a toothbrush. We ...
(Date:9/2/2014)... Tuesday 2 September 2014: The fact that mechanical ... been confirmed by data from the ROPAC registry presented ... Hot Line session by Professor Jolien W. Roos-Hesselink, co-chair ... The registry found that 1.4% of pregnant women with ... baby during pregnancy. , The Registry Of Pregnancy And ...
Breaking Medicine News(10 mins):Health News:Magician Misty Lee is the First and Only Female Staff Medium at Hollywood’s Magic Castle 2Health News:James Taylor Presale Tickets for 10 November Concerts On Sale Today From Trusted Provider QueenBeeTickets.com 2Health News:NYU study compares consequences of teen alcohol and marijuana use 2Health News:NYU study compares consequences of teen alcohol and marijuana use 3Health News:Smile Squared's Colorful Buy One, Give One Toothbrush Now Available in Schnucks Stores 2Health News:Mechanical heart valves increase pregnancy risk 2Health News:Mechanical heart valves increase pregnancy risk 3
... that treats Type-2 diabetes has been shown to prevent ... the growth of breast cancer cells, according to a ... The research, led by pediatrics professor James Trosko ... biological evidence for previously reported epidemiological surveys that long-term ...
... European Science Foundation (ESF) has awarded this year,s European ... Max Planck Institute for Demographic Research in Rostock, Germany. ... Vaupel was awarded the prize for his contributions to ... on demographic research. The Prize was awarded on the ...
... How will the terrorist attacks in Norway on 22 July ... social scientists at the University of Stavanger (UiS). "Norwegians ... Einar Olsen. "These incidents were so extensive and gruesome that ... He is very interested to see what content Norway will ...
... for cancer and epilepsy could also prevent heart attacks, according ... Gothenburg, Sweden, who have been using it to stimulate the ... are normally caused by the formation of a blood clot ... with oxygen and nutrients. The clot reduces the supply of ...
... News) -- Some patients with inflammatory bowel disease may ... their use of immunosuppressant drugs to treat the intestinal ... The studies, published in the November issue of ... commonly used to treat patients with irritable bowel disease, ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, ... "energy" drinks skyrockets, so do related health problems, a ... almost 10 times more cases of reactions to beverages such ... to a new U.S. government report released Tuesday. More ...
Cached Medicine News:Health News:Diabetes drug shows promise in reducing risk of cancer 2Health News:ESF awards 13th European Latsis Prize to James Vaupel on pioneering demographic research 2Health News:Coming to terms with terror 2Health News:Coming to terms with terror 3Health News:Coming to terms with terror 4Health News:Substance in cancer medicine could prevent heart attacks 2Health News:Chronic Bowel Disease Drugs Linked to Skin Cancer Risk 2Health News:ER Visits for Energy-Drink Ills Soar in U.S. 2Health News:ER Visits for Energy-Drink Ills Soar in U.S. 3
... Atlantech's new tibial guide is designed for ... to choose between "point" or "elbow" aimers ... for creation of the tibial tunnel. The ... design features and the reproducibility and accuracy ...
The Pinn-ACL Guide can be used to create tibial tunnels of known lengths with a variable angle adjustment of 35 to 60 degrees with the use of a,graduated pin-sleeve....
Hand surgery basic instrument set...
Hand surgery basic instrument set with round handled instruments...
Medicine Products: